Stability analysis of recombinant human TFF2 and its therapeutic effect on burn-induced gastric injury in mice

Burns

Volumn 35, Issue 6, 2009, Pages 869-874

  Yong, Sun ^a,b   Wu, Wei ^a   Zhang, Yong ^a   Lv, Shangjun ^a   Wang, Lin ^a   Wang, Shiliang ^a   Peng, Xi ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b The No 97 Hospital   (China)

Author keywords

Escherichia coli; Gastric injury; Stability; TFF2

Indexed keywords

ACID; ALKALI; RECOMBINANT PROTEIN; TRECOIL FACTOR FAMILY 2 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURN; CONTROLLED STUDY; ESCHERICHIA COLI; GENE SEQUENCE; GENETIC RECOMBINATION; HEAT; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN PURIFICATION; SIMULATION; STOMACH INJURY;

ANIMALS; BURNS; DRUG EVALUATION, PRECLINICAL; DRUG STABILITY; GASTRIC MUCOSA; HOT TEMPERATURE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MICE; NECROSIS; PEPTIDE HYDROLASES; PEPTIDES; RECOMBINANT PROTEINS; WOUND HEALING;

EID: 67651161871     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2008.12.002     Document Type: Article

References (25)

1. Hoffmann W., and Jagla W. Cell type specific expression of secretory TFF peptides: colocalization with mucins and synthesis in the brain. Int Rev Cytol 213 (2002) 147-181
2. Taupin D., and Podolsky D.K. Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 4 (2003) 721-732
3. May F.E.B., Semple J.I., Newton J.L., and Westley B.R. The human two domain trefoil protein, TFF2, is glycosylated in vivo in the stomach. Gut 46 (2000) 454-459
4. Rio M.C., Bellocq J.P., Daniel J.Y., Tomasetto C., Lathe R., Chenard M.P., et al. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science 241 (1988) 705-708
5. Tomasetto C., Rio M.C., Gautier C., Wolf C., Hareuveni M., Chambon P., et al. hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO J 9 (1990) 407-414
6. Suemori S., Lynch-Devaney K., and Podolsky D.K. Identification and characterization of rat intestinal trefoil factor: tissue-and cell-specific member of the trefoil protein family. Proc Natl Acad Sci USA 88 (1991) 11017-11021
7. Babyatsky M.W., de Beaumont V., Thim L., and Podolsky D.K. Oral trefoil peptides protect against ethanol and indomethacin-induced gastric injury in rats. Gastroenterology 110 (1996) 489-497
8. Cook G.A., Thim L., Yeomans N.D., and Giraud A.S. Oral human spasmolytic polypeptide protects against aspirin-induced gastric injury in rats. J Gastroenterol Hepatol 13 (1998) 363-370
9. Guth P.H., Aures D., and Paulsen G. Topical aspirin plus HCL gastric lesions in the rat. Cytoprotective effect of prostaglandin, cimetidine, and probanthine. Gastroenterology 76 (1979) 88-93
10. Studier F.W., and Moffatt B.A. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol 189 (1986) 113-130
11. Rosenberg A.H., Lade B.N., Chui D.S., Lin S.W., Dunn J.J., and Studier F.W. Vectors for selective expression of cloned DNAs by T7 RNA polymerase. Gene 56 (1987) 125-135
12. Studier F.W., Rosenberg A.H., Dunn J.J., and Dubendorff J.W. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 185 (1990) 60-89
13. Pauletti G., Gangwar S., Knipp G.T., Nerurkar M.M., Okuma F.W., Tamura K., et al. Structural requirements for intestinal absorption of peptide drugs. J Control Release 41 (1996) 3-17
14. Carinp G.P., and Mathiowitz E. Oral insulin delivery. Adv Drug Deliv Rev 35 (1999) 249-257
15. Sun Y., Peng X., Zhang Y., Lv S., Wu W., and Wang S. Stability and biological activity of human intestinal trefoil factor produced by Pichia pastoris. Protein Pept Lett 15 (2008) 255-259
16. Kjellev S., Vestergaard E.M., Nexo E., Thygesen P., Eghøj M.S., Jeppesen P.B., et al. Pharmacokinetics of trefoil peptides and their stability in gastrointestinal contents. Peptides 28 (2007) 1197-1206
17. Carrasco R., Pera M., May F.E., Westley B.R., Martinez A., and Morales L. Trefoil factor family peptide 3 prevents the development and promotes healing of ischemia-reperfusion injury in weanling rats. J Pediatr Surg 39 (2004) 1693-1700
18. Robert P.H. Clinical burn therapy: a management and prevention guide (1982), PSG, Boston, MA p. 411-29
19. Wallace J.L., and Granger D.N. The cellular and molecular basis of gastric mucosal defense. FASEB J 10 (1996) 731-740
20. Gajhede M., Petersen T.N., Henriksen A., Petersen J.F., Dauter Z., Wilson K.S., et al. Pancreatic spasmolytic polypeptide: first three-dimensional structure of a member of the mammalian trefoil family of peptides. Structure 1 (1993) 253-262
21. Tomasetto C., Masson R., Linares J.L., Wendling C., Lefebvre O., Chenard M.P., et al. pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. Gastroenterology 118 (2000) 70-80
22. Dignass A.U., Lynch-Devaney K., Kindon H., Thim L., and Podolsky D.K. Trefoil peptides promote epithelial migration through a TGF-β independent pathway. J Clin Investig 94 (1994) 376-383
23. Efstathiou J.A., Noda M., Rowan A., Dixon C., Chinery R., Jawhari A., et al. Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells. Proc Natl Acad Sci USA 95 (1998) 3122-3127
24. Liu D., el-Hariry I., Karayiannakis A.J., Wilding J., Chinery R., Kmiot W., et al. Phosphorylation of beta-catenin and epidermal growth factor receptor by intestinal trefoil factor. Lab Invest 77 (1997) 557-563
25. Chinery R., and Playford R.J. Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethacin induced gastric damage in the rat. Clin Sci 88 (1995) 401-403